Uncategorized

Square cover image of Alijie Biotech participating in the 2025 Taiwan Healthcare+ Expo.

Healthcare+ Expo Taiwan: Advancing Global Cancer Detection with OkaiDx™

The four-day Healthcare+ Expo Taiwan has successfully come to an end! We extend our sincere gratitude to every physician, researcher, industry partner, and health-conscious visitor who visited our booth. The insightful discussions we shared underscore our collective mission to transform the future of healthcare. Transforming Cancer Care Through Innovation At EG BioMed US, we are […]

Healthcare+ Expo Taiwan: Advancing Global Cancer Detection with OkaiDx™ Read More »

EG BioMed Joins PurpleStride 2025

EG BioMed Supports Pancreatic Cancer Awareness at PurpleStride 2025

EG BioMed was honored to sponsor and participate in PurpleStride 2025, hosted by the Pancreatic Cancer Action Network (PanCAN) on April 26, 2025. The event served as a powerful platform to raise awareness about pancreatic cancer and promote innovation in early detection. The event gathered pancreatic cancer patients, families, clinicians, researchers, and supporters from across

EG BioMed Supports Pancreatic Cancer Awareness at PurpleStride 2025 Read More »

EG BioMed Partners with Taipei Medical University to Develop Breakthrough Cancer Detection Technology for Ten Major Cancers

EG BioMed is working closely with Taipei Medical University and its three affiliated hospitals to pioneer a revolutionary blood test for the early detection of ten major cancers. These cancers include some of the most common and deadly types, such as breast, colon, rectal, esophageal, stomach, lung, pancreatic, prostate, ovarian, uterine, and liver cancers. This

EG BioMed Partners with Taipei Medical University to Develop Breakthrough Cancer Detection Technology for Ten Major Cancers Read More »